AstroNova Reiterates FY25 Organic Revenue Growth In The Mid-Single Digits And Cut Adj EBITDA Margin To 9%-10% (Prior 13%-14%), Expects FY25 Adj EBITDA Margin Of 13%-14%
Portfolio Pulse from Benzinga Newsdesk
AstroNova has adjusted its FY25 financial outlook, maintaining mid-single-digit organic revenue growth but lowering its adjusted EBITDA margin estimate to 9%-10% due to the MTEX integration. The company expects to achieve a 13%-14% EBITDA margin by FY26.
September 16, 2024 | 11:35 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
AstroNova has revised its FY25 financial outlook, maintaining mid-single-digit organic revenue growth but reducing its adjusted EBITDA margin estimate to 9%-10% due to the MTEX integration. The company anticipates a 13%-14% EBITDA margin by FY26.
AstroNova's reduction in the adjusted EBITDA margin for FY25 due to the MTEX integration suggests potential short-term financial challenges, which may negatively impact investor sentiment and the stock price. However, the company maintains its revenue growth outlook and expects margin recovery by FY26.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100